November 3, 2020

Vigene Strengthens Management Team with Another Ke...

Vigene Biosciences announces today another key executive addition. Audrey Chang, Ph.D. is appointed as the VP of QC and Analytical Services.
October 12, 2020

Vigene Strengthens Management Team Critical Execut...

Vigene Biosciences announces today an executive addition. Molly McGlaughlin is appointed as Chief Operation Officer.
October 9, 2020

Rznomics Announces Manufacturing Agreement with Vi...

Vigene has entered a contract manufacturing agreement with Rznomics Inc. for its leading pipeline product, RZ-001. RZ-001 is a gene therapy for advanced hepatocellular carcinoma (HCC).
August 31, 2020

Vigene Biosciences made the 2020 Inc. 5000 list of...

Vigene Biosciences made the 2020 Inc. 5000 list of the fastest-growing private companies in America!
July 22, 2020

Altimmune Announces Manufacturing Agreement with V...

Vigene entered an agreement with Altimmune to manufacture its single-dose intranasal vaccine candidate for COVID-19.
June 4, 2020

Vigene Biosciences Awarded Patent for improvements...

The modifications on AAV vector leads to 2-4 folds increase in production yield.
May 5, 2020

Vigene’s Webinar Series on Viral Vector and ...

Join our monthly live webinars to interact with our scientists. Vigene's viral vector and plasmid production technology webinar series
March 27, 2020

Vigene Joins the Fight Against COVID-19 – M...

Vigene has joined the fight against COVID-19 by helping manufacture vaccines for COVID-19.
March 23, 2020

Vigene’s COVID-19 Update – March 23rd,...

We would like to update you on the precautions and actions that Vigene Biosciences is taking due to the rapidly […]
February 27, 2020

Maryland Biotech Opens New Gene Therapy Contract M...

BioBuzz reported on the grand opening of Vigene Biosciences’s new 51,000 square feet GMP manufacturing facility.